Human Stories in AI: Fabio Urbina

TL;DR

Fabio Urbina shares his career journey combining computational tools and machine learning for drug discovery.

Transcript

hello I'm Josh starmer and welcome to human stories and AI with stack Quest and lightning AI in this series we'll hear about the career journeys of passionate AI experts from their humble beginnings to conquered challenges will be inspired by the realworld experiences of professionals thriving in the ever evolving AI landscape human stories and AI ... Read More

Key Insights

• 🎰 Fabio's career journey blends biology, computational tools, and machine learning in drug discovery.
• ❓ Collaboration Pharmaceuticals focuses on rare diseases, offering a unique approach to drug development.
• 🎰 Machine learning enables rapid screening of potential drug candidates, optimizing the drug discovery process.
• 😫 Small data sets present challenges in machine learning, requiring innovative solutions like prototypical networks.
• ❓ Simple models like prototypical networks can outperform complex models, offering efficient drug discovery solutions.
• ❓ Adopting a growth mindset and embracing discomfort in learning accelerates career transitions and skill development.
• 💻 Diverse backgrounds like biology and computer science are essential in tackling complex scientific problems.

Questions & Answers

Q: How did Fabio's childhood interest in science shape his career path?

Fabio's childhood interest in science and computers drove his academic focus, leading to a career in biology and computational tools for drug discovery.

Q: What motivated Fabio to transition from academia to industry?

Fabio's internship experience in rare disease drug discovery at Collaboration Pharmaceuticals sparked his interest in industry, leading to applying his computational biology skills in the field.

Q: How does machine learning aid in early stage drug discovery?

Machine learning helps predict compound efficacy for diseases like malaria, enabling researchers to narrow down potential drug candidates for testing, optimizing the drug discovery process.

Q: What challenges does Fabio face with small data sets in machine learning?

Fabio addresses the challenge of small data sets by using prototypical networks and careful data curation to make accurate predictions for drug discovery, demonstrating innovative problem-solving techniques.

Summary & Key Takeaways

• Fabio Urbina shares his career journey from biology studies to drug discovery using machine learning.

• He started as an intern at Collaboration Pharmaceuticals and rose to the position of an associate director.

• Fabio utilizes prototypical networks in small data sets for early stage drug discovery with a focus on rare diseases.